COLLABORATIVE INNOVATION

Seeding tomorrow’s priority medicines
Our resources
your results

Drug target & assays
Helping you

to create new medicines

Concept
Our expertise
your creativity

Results

European Lead Factory

Latest news

25 February 2021

March webinar: High Content Screening at the European Lead Factory

10 February 2021

ELF webinar: Guidelines for High Throughput Screening assay development

28 January 2021

New study elucidates role of tryptophan-metabolizing enzymes in cancer immunotherapy

Call for proposals

Find out how you can boost your drug discovery programme and submit your screening proposal today

Publications

28 January 2021

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0

31 July 2020

Hit discovery for public target programmes in the European Lead Factory: Experiences and output from assay development and ultra-High Throughput Screening

View all publications

European Lead Factory

The ELF concept
Take a look at this award-winning
animation explaining the ELF concept
and how it helps to boost drug discovery.

Your target, your results
The European Lead Factory welcomes
drug targets in all disease areas.
Learn how you can benefit and give
your drug discovery research a flying start!
View all animations

Events

11 March 2021

Webinar: High Content Screening at the European Lead Factory

View all events

Testimonials

Margit Mahlapuu

Associate Professor in Medicine Inst. of Medicine, University of Gothenburg

https://www.elf.elonisas.nl/results/testimonials#Margit

Chris Swain, PhD

Director / Founder Cambridge MedChem Consulting

https://www.elf.elonisas.nl/results/testimonials#ChrisSwain

William Unsworth, PhD

Leverhulme Trust Early Career Research Fellow Department of Chemistry, University of York

https://www.elf.elonisas.nl/results/testimonials#WilliamUnsworth

Tweets by EULeadFactory

http://www.merckgroup.com/en/index.html

http://www.janssen.com/

http://www.astrazeneca.com

http://www.bayerpharma.com

http://www.lundbeck.com

http://en.sanofi.com/

http://www.ucb.com

http://www.tarosdiscovery.com

http://www.edelris.com

http://www.sygnaturediscovery.com

http://www.mercachemsyncom.com

http://www.arttic.eu/pages/en/home.php

http://www.lygature.org

http://www.bioascent.com

http://www.chemaxon.com

http://www.lead-discovery.de

http://www.pivotparkscreeningcentre.com

http://www.lifesci.dundee.ac.uk

http://www.leiden.edu

http://www.lumc.nl

http://www.mpi-dortmund.mpg.de

http://www.ru.nl/imm/

http://www.drugdesign.nl

http://www.dtu.dk

http://www.uni-due.de/en/

http://www.asn.leeds.ac.uk

http://www.nottingham.ac.uk/chemistry

http://www.ox.ac.uk

http://www.chem.vu.nl/en/index.asp

https://www.mmv.org/

https://www.grunenthal.com/

http://www.servier.com

© European Lead Factory and its partners.

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n' 115489, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7 / 2007-2013) and EFPIA companies' in kind contribution.

This project has also received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806948: ‘ESCulab: European Screening Centre; Unique Library for Attractive Biology’. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Medicines for Malaria Venture (MMV).